Gamma Medica-Ideas closes $24M financing round
Molecular imaging system developer Gamma Medica-Ideas has closed its first institutional round of financing and raised $24 million.
The Northridge, Calif.-based firm said the capital will be used to support continued growth of the company's proprietary digital SPECT, PET and CT technologies in current and new markets. The financing was comprised of $14 million in equity capital, $5 million in mezzanine debt, and a $5 million in a revolving line of credit.
Psilos Group, a leading healthcare venture capital firm, led the equity round. Capital Resource Partners, a leading provider of hybrid growth financing solutions, participated alongside Psilos in the equity round and provided mezzanine debt. The technology lending group at Bridge Ban rounded out the financing with a revolving line of credit.
The Northridge, Calif.-based firm said the capital will be used to support continued growth of the company's proprietary digital SPECT, PET and CT technologies in current and new markets. The financing was comprised of $14 million in equity capital, $5 million in mezzanine debt, and a $5 million in a revolving line of credit.
Psilos Group, a leading healthcare venture capital firm, led the equity round. Capital Resource Partners, a leading provider of hybrid growth financing solutions, participated alongside Psilos in the equity round and provided mezzanine debt. The technology lending group at Bridge Ban rounded out the financing with a revolving line of credit.